Current Opinion in Neurology

Article	Citations
The role of innate immune genes in Alzheimer's disease	92
Mechanisms underlying progression in multiple sclerosis	86
Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management	77
Where are we moving in the classification of idiopathic inflammatory myopathies?	66
Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?	61
Current advances in plasma and cerebrospinal fluid biomarkers in Alzheimer's disease	52
Amyotrophic lateral sclerosis: update on clinical management	45
What has been the impact of new drug treatments on epilepsy?	44
Novel insights into pathophysiology and therapeutic possibilities reveal further differences between AQP4-IgG- and MOG-IgG-associated diseases	44
Cognitive and behavioural impairment in amyotrophic lateral sclerosis	44
Tremor pathophysiology: lessons from neuroimaging	43
MRI findings as markers of idiopathic intracranial hypertension	43
The state of telemedicine for persons with Parkinson's disease	43
Linking mechanisms of periodontitis to Alzheimer's disease	42
Serious video games and virtual reality for prevention and neurorehabilitation of cognitive decline because of aging and neurodegeneration	41
What is ‘Alzheimer's disease’? The neuropathological heterogeneity of clinically defined Alzheimer's dementia	39
Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies	38
Acute bacterial meningitis	36
Update on neuroimaging in disorders of consciousness	35
Motion sickness: current concepts and management	35
Advanced neuroimaging in neuropsychiatric systemic lupus erythematosus	34
Wilson disease	33
Chance and risk in epilepsy	33
Chronic inflammation mediates brain injury in HIV infection: relevance for cure strategies	33
Amyotrophic lateral sclerosis is a systemic disease: peripheral contributions to inflammation-mediated neurodegeneration	32

Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease: current topics	32
Epilepsy, antiepileptic drugs and dementia	30
Localizing the epileptogenic zone	30
What are the epileptic encephalopathies?	29
Machine learning for classification and prediction of brain diseases: recent advances and upcoming challenges	27
The elusive promise of myostatin inhibition for muscular dystrophy	27
Advances in the treatment of neuropathic pain	26
The window of opportunity for treatment of progressive multiple sclerosis	26
Dravet syndrome	26
Measuring outcomes that matter most to people with multiple sclerosis: the role of patient-reported outcomes	26
E-health and multiple sclerosis	26
Update on genetics of amyotrophic lateral sclerosis	25
MRI of neurodegeneration with brain iron accumulation	24
Prevention and management of adverse effects of disease modifying treatments in multiple sclerosis	23
Vaccinations in multiple sclerosis patients receiving disease-modifying drugs	23
Frontotemporal dementias: main syndromes and underlying brain changes	22
Fragile X-associated tremor/ataxia syndrome: pathophysiology and management	22
MRI in disorders of consciousness	21
Neuralgic amyotrophy	21
Advances in physical rehabilitation of multiple sclerosis	21
Biomarkers in amyotrophic lateral sclerosis: a review of new developments	20
Update on T cells in the virally infected brain: friends and foes	20
Functional MRI in migraine	19
Interictal autonomic dysfunction	19
Stroke epidemiology and COVID-19 pandemic	19
The biological basis of chronic fatigue: neuroinflammation and innate immunity	19
Therapeutic strategies for Huntington's disease	19
Prediction of motor recovery after stroke: being pragmatic or innovative?	19
Overview of tau PET molecular imaging	18
Anti-gamma-aminobutyric acid receptor type A encephalitis: a review	18
Current trends in the clinical trial landscape for amyotrophic lateral sclerosis	17
Rehabilitation of cortically induced visual field loss	17
The increasing role of muscle MRI to monitor changes over time in untreated and treated muscle diseases	17
Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities	17
Use of disease-modifying drugs during pregnancy and breastfeeding	17
Microglia in multiple sclerosis – pathogenesis and imaging	17
Lesion network mapping for symptom localization: recent developments and future directions	16
Management of autoimmune encephalitis	16
Vestibular and auditory manifestations of migraine	16
Neuromuscular complications of coronavirus disease-19	16
Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis	16
What have we learned from cognition in the oldest-old	16
Current concepts in acute vestibular syndrome and video-oculography	15
The recent surge of functional movement disorders: social distress or greater awareness?	15
Central nervous system tuberculosis	15
Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?	15
Stopping disease-modifying therapy in relapsing and progressive multiple sclerosis	15
Data science in neurodegenerative disease: its capabilities, limitations, and perspectives	15
Insular seizures and epilepsies: Ictal semiology and minimal invasive surgery	14
Neuropathogenesis of acute coronavirus disease 2019	14

New drugs for multiple sclerosis: new treatment algorithms	14
MR imaging and spectroscopy in degenerative ataxias: toward multimodal, multisite, multistage monitoring of neurodegeneration	13
Intravenous thrombolysis for acute ischemic stroke: why not?	13
Deep brain stimulation in dystonia: factors contributing to variability in outcome in short and long term follow-up	13
Unveiling the neuroimaging-genetic intersections in the human brain	13
Chemotherapy and targeted therapies for meningiomas: what is the evidence?	13
Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment	13
The cognitive costs, contraindications and complications of epilepsy surgery in adults	13
Multiple sclerosis in the era of COVID-19: disease course, DMTs and SARS-CoV2 vaccinations	12
Update on the management of status epilepticus	12
Reproducibility and replicability in neuroimaging data analysis	12
Methods of visual assessment in children with cortical visual impairment	12
Advances in the genetic classification of amyotrophic lateral sclerosis	12
Persistent inflammatory states and their implications in brain disease	12
Therapeutic strategies for C9orf72 amyotrophic lateral sclerosis and frontotemporal dementia	12
Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and management	12
A reappraisal of injuries and accidents in people with epilepsy	12
Novel pathophysiological insights in autoimmune myasthenia gravis	12
Antibody testing in neuropathy associated with anti-Myelin-Associated Glycoprotein antibodies: where we are after 40 years	12
Learning from the comorbidities of epilepsy	12
Posttraumatic headache: recent progress	11
The role of telemedicine in acute stroke treatment in times of pandemic	11
Autoimmune nodopathies, an emerging diagnostic category	11
Updates on ophthalmic imaging features of optic disc drusen, papilledema, and optic disc edema	11
Quantitative MRI markers in Parkinson's disease and parkinsonian syndromes	11
Targets for migraine treatment: beyond calcitonin gene-related peptide	11
Long COVID and especially headache syndromes	11
Sudden unexpected death in epilepsy	11
Peripheral white blood cell responses as emerging biomarkers for patient stratification and prognosis in acute spinal cord injury	11
Hereditary transthyretin amyloidosis: current treatment	11
Vestibular-autonomic interactions: beyond orthostatic dizziness	11
Recent therapeutic prospects for Machado–Joseph disease	11
Advanced neuroimaging techniques in epilepsy	11
Central vein sign and iron rim in multiple sclerosis: ready for clinical use?	10
Ataxin-2 gene: a powerful modulator of neurological disorders	10
Telemedicine for neuro-ophthalmology: challenges and opportunities	10
Contribution of PET-MRI in brain diseases in clinical practice	10
Sleep in disorders of consciousness: diagnostic, prognostic, and therapeutic considerations	10
Immunotherapy in autoimmune encephalitis	10
Magnetic resonance spectroscopy of isocitrate dehydrogenase mutated gliomas: current knowledge on the neurochemical profile	10
Influence of sex hormones on vestibular disorders	10
Data-driven approaches to neuroimaging biomarkers for neurological and psychiatric disorders: emerging approaches and examples	10
Triggers of migraine: where do we stand?	10
Cancer stem cells in gliomas: evolving concepts and therapeutic implications	10
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis	10
Novel approaches to prediction in severe brain injury	10
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases	10
Why do seizures impair consciousness and how can we reverse this?	10
Update on neuroimaging in brain tumours	10
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection	9
Brief exposure to systemic hypoxia enhances plasticity of the central nervous system in spinal cord injured animals and man	9
Biomarkers for amyotrophic lateral sclerosis	9
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes	9
Predicting disability worsening in relapsing and progressive multiple sclerosis	9
Central nervous system injury from novel cancer immunotherapies	9
Bilateral vestibulopathy: the causes, diagnosis, and treatments	9
Attention deficit/hyperactivity disorder and epilepsy	9
Ménière's disease: new guidelines, subtypes, imaging, and more	9
Ultra-high field 7 T imaging in multiple sclerosis	8
Is chemotherapy alone an option as initial treatment for low-grade oligodendrogliomas?	8
Vestibular function testing in the 21st century: video head impulse test, vestibular evoked myogenic potential, video nystagmography; which tests will provide answers?	8
Facial pain beyond trigeminal neuralgia	8
The constantly evolving spectrum of phenotypes in titinopathies – will it ever stop?	8
Deciphering the contributions of neuroinflammation to neurodegeneration: lessons from antibody-mediated encephalitis and coronavirus disease 2019	8
Cerebellar ataxia, neuropathy, vestibular areflexia syndrome: genetic and clinical insights	8
Magnetic resonance-guided focused ultrasound for movement disorders: clinical and neuroimaging advances	8
Immunotherapy in progressive supranuclear palsy	8
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies	8
Contraception, fecundity, and pregnancy in women with epilepsy: an update on recent literature	8
Autoimmune movement disorders with neuronal antibodies – an update	8
Targeting IDH1/IDH2 mutations in gliomas	8
Recent advances in pharmacotherapy for epilepsy	8
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	8
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	8
Visual field defects in temporal lobe epilepsy surgery	8
Highly effective disease-modifying treatment as initial MS therapy	8
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies	7
Hereditary motor neuropathies	7
Small fiber neuropathies: expanding their etiologies	7
Update on dermatomyositis	7

Network dysfunction in pre and postsurgical epilepsy: connectomics as a tool and not a destination	7
Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion	7
Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis	7
Oculopharyngodistal myopathy	7
Targeting gene fusions in glioma	7
Parkinson's disease – genetic cause	7
New insights into the Immune TME of adult-type diffuse gliomas	7
Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment	7
Recent advances in our understanding of genetic rhabdomyolysis	7
Serotonergic therapy in epilepsy	7
Drug interactions and risks associated with the use of triptans, ditans and monoclonal antibodies in migraine	7
Immunotherapy approaches for adult glioma: knowledge gained from recent clinical trials	7
COVID-19 associated myopathy	6
Central nervous system infections and antimicrobial resistance: an evolving challenge	6
Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients	6
Historical development and contemporary use of neuromodulation in human spinal cord injury	6
The prospects of targeting DUX4 in facioscapulohumeral muscular dystrophy	6
Promoting exogenous repair in multiple sclerosis: myelin regeneration	6
Update on neuroimaging for categorization of Parkinson's disease and atypical parkinsonism	6
Neuromuscular hyperexcitability syndromes	6
Advances in the management of acute ischemic stroke	6
Traumatic peripheral nerve injuries: diagnosis and management	6
Expanding the clinical spectrum of idiopathic intracranial hypertension	6
Combined neuromodulatory approaches in the central nervous system for treatment of spinal cord injury	6
The 2020 breakthroughs in early secondary prevention: dual antiplatelet therapy versus single antiplatelet therapy	6
Update on neuroimaging in non-Alzheimer's disease dementia: a focus on the Lewy body disease spectrum	6
Neurology education in the era of artificial intelligence	6
Noninvasive neuromodulation and rehabilitation to promote functional restoration in persons with spinal cord injury	6
MRI and laboratory monitoring of disease-modifying therapy efficacy and risks	5
Updates on management of headache in women and transgender women	5
Interrogating large multiple sclerosis registries and databases: what information can be gained?	5
Emerging approaches in neurostimulation for epilepsy	5
Emerging infectious encephalitides	5
Socioeconomic disparities in epilepsy care	5
Targeting B cells in multiple sclerosis	5
Acute stroke treatment during coronavirus disease 2019 pandemic	5
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease	5
Sudden unexpected death in epilepsy	5
Recent genetic advances in early-onset dystonia	5
Review and update in the diagnosis of peripheral nerve sheath tumors	5
Fluid phase biomarkers in multiple sclerosis	5
Update on alpha-synuclein-based biomarker approaches in the skin, submandibular gland, gastrointestinal tract, and biofluids	5
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	5
Connecting tremors – a circuits perspective	5
Myogenic tremor – a novel tremor entity	5
Neuromodulation in primary headaches: current evidence and integration into clinical practice	5
Update in the clinical application of focused ultrasound	4
Stroke in the young	4
Update on myelin imaging in neurological syndromes	4
Impaired neurocognitive function in glioma patients: from pathophysiology to novel intervention strategies	4
Neuromuscular complications of cancer therapy	4
Rescue therapies in epilepsy	4
Neuromuscular junction disorders beyond myasthenia gravis	4
Shifting acute stroke management to the prehospital setting	4
The apparent paradox of phenotypic diversity and shared mechanisms across dystonia syndromes	4
Evaluating thunderclap headache	4
The current landscape of epilepsy genetics: where are we, and where are we going?	4
Medication overuse headache	4
Hereditary motor neuropathies	4
Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke	4
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	4
Hypoventilation syndrome in neuromuscular disorders	4
Optic neuritis: current challenges in diagnosis and management	4
Atypical chronic inflammatory demyelinating polyradiculoneuropathy: recent advances on classification, diagnosis, and pathogenesis	4
Imaging of sleep disorders in pre-Parkinsonian syndromes	4
Cerebrospinal fluid circulating tumour DNA as a liquid biopsy for central nervous system malignancies	4
Advanced imaging in acute ischemic stroke: an updated guide to the hub-and-spoke hospitals	4
Digital health in stroke medicine: what are the opportunities for stroke patients?	4
Progression in multiple sclerosis – a long-term problem	4
Therapies targeting CGRP signaling for medication overuse headache	4
Neurological adverse events of immune checkpoint blockade: from pathophysiology to treatment	4
Autoimmune neuromyotonia	4
Update on neuroimaging in Alzheimer's disease	4
Progress in spinal muscular atrophy research	4
Genetic therapy for congenital myopathies	4
Inclusion body myositis: evolving concepts	4
Microglia at the scene of the crime: what their transcriptomics reveal about brain health	4
Recent advances in establishing a cure for GNE myopathy	4